DGAP-News: CureVac Accelerates Oncology Strategy with Acquisition of Frame Cancer Therapeutics, Adding Novel Antigen Discovery Platform
|
Issuer: CureVac
/ Key word(s): Takeover
CureVac Accelerates Oncology Strategy with Acquisition of Frame Cancer Therapeutics, Adding Novel Antigen Discovery Platform 08.06.2022 / 22:10 The issuer is solely responsible for the content of this... |